NRSN NeuroSense Therapeutics Ltd.: institutional ownership and insider trading
11 funds reported holding $286K of NeuroSense Therapeutics Ltd. in their latest 13F filings; in Q2 2026 funds net bought $12.9K, with 2 new positions and 3 funds selling out; over the last 12 months insiders bought $400K and sold $0 on the open market.
Largest institutional holders of NRSN
- UBS Group AG (UBS) — $78.2K
- Independent Advisor Alliance — $72.0K
- Yorkville Advisors Global, LP — $56.2K
- COMMONWEALTH EQUITY SERVICES, LLC — $16.4K
- PNC FINANCIAL SERVICES GROUP, INC. (PNC) — $15.2K
- Pathstone Holdings, LLC — $11.9K
- GEODE CAPITAL MANAGEMENT, LLC — $11.4K
- XTX Topco Ltd — $8.26K
- Creative Planning — $8.22K
- HRT FINANCIAL LP — $7.00K
Recent NRSN insider trades
- Jun 16, 2026: Ben-Noon Alon bought 250,000 shares ($200K)
- Jun 16, 2026: Eisenberg Or bought 250,000 shares ($200K)